Latest Administration News

WAM Active Limited has reported a robust half-year performance with a 33.2% increase in net profit and a fully franked interim dividend of 3.0 cents per share, underscoring its commitment to shareholder returns despite ongoing legal challenges.

HUB24 has delivered a robust half-year performance for 1HFY25, marked by significant revenue growth, record net inflows, and expanding adviser engagement, reinforcing its leadership in Australia’s wealth management technology sector.

HUB24 has delivered a standout first half of FY25, posting record platform net inflows of $9.5 billion and a 40% rise in underlying net profit, reinforcing its position as a market leader in Australia’s wealth management sector.

HUB24 has reported a robust first half FY25 with a 41% jump in underlying EBITDA and upgraded its FY26 platform funds under administration target, underscoring its accelerating market momentum.

HUB24 Limited has reported robust growth in its half-year results to December 2024, with revenue climbing 25% and underlying net profit after tax soaring 40%. The company also announced a 30% increase in its fully franked interim dividend, underscoring confidence in its ongoing momentum.

Challenger Limited reported a robust first half of FY25 with a 12% rise in normalized NPAT and a 12% increase in its interim dividend, driven by strong annuity sales and strategic technology investments.

Challenger Limited has reported a robust first half of FY25, with a 12% increase in normalized NPAT and significant strides in annuity sales and technology modernization, positioning the company for sustained growth.

Challenger Limited reported a robust 12% increase in normalized NPAT to $225 million for 1H25, underpinned by strong earnings, dividend growth, and strategic investments in technology and distribution channels.

Challenger Limited reported a robust first half of FY25, delivering a 12% rise in normalised net profit after tax and record annuity sales, underpinned by strategic technology investments and longer tenor products.

Far Northern Resources has amended its December 2024 Appendix 5B cash flow report to provide clearer details on investing activities, revealing a net cash outflow and a modest cash balance at quarter-end.

Australian Bond Exchange Holdings has entered a strategic Liquidity Provision Agreement with ViewTrade Australia, aiming to broaden investor access to OTC securities globally through integrated technology and expanded market channels.

Neurizon Therapeutics received FDA guidance on its IND application for NUZ-001, with a single request for additional animal exposure data but no safety concerns flagged. The company is actively addressing the FDA’s request while evaluating impacts on its ALS trial timeline.